Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment

被引:32
作者
Song, Qian-Qian [1 ,2 ]
Xie, Wan-Ying [1 ,2 ]
Tang, Yong-Jun [1 ,2 ]
Zhang, Jun [3 ]
Liu, Jie [1 ,2 ]
机构
[1] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410008, Hunan, Peoples R China
[2] Cent S Univ, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha 410078, Hunan, Peoples R China
[3] Cent S Univ, Xiangya Hosp, Dept Nephrol, Changsha 410008, Hunan, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
glucocorticoid; glucocorticoid pathway; glucocorticoid resistance; pharmacogenetics; polymorphisms; ACUTE LYMPHOBLASTIC-LEUKEMIA; INFLAMMATORY-BOWEL-DISEASE; IMPROVED LUNG-FUNCTION; LIGAND-BINDING DOMAIN; PERIPHERAL-BLOOD LYMPHOCYTES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; P-GLYCOPROTEIN EXPRESSION; RECEPTOR GENE; NEPHROTIC SYNDROME; POINT MUTATION;
D O I
10.2217/pgs-2016-0151
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glucocorticoids (GCs) are widely used for treating asthma, rheumatoid arthritis, nephrotic syndrome, acute lymphoblastic leukemia and other autoimmune diseases. However, in a subgroup of patients, failure to respond to GCs is known as GC resistance or GC insensitivity. This represents an important barrier to effective treatment and a clinical problem requiring an urgent solution. Genetic variation in the GC pathway is a significant factor in interindividual differences in GC treatment. This article reviews the pharmacogenetics of GCs in diverse diseases based on the GC pathway.
引用
收藏
页码:293 / 316
页数:24
相关论文
共 171 条
[61]   MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children [J].
Jafar, Tabrez ;
Prasad, Narayan ;
Agarwal, Vikas ;
Mahdi, Abbas ;
Gupta, Amit ;
Sharma, Raj K. ;
Negi, Mahendra Pal Singh ;
Agrawal, Suraksha .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (12) :3968-3974
[62]   Glucocorticoid receptor isoforms in steroid-dependent asthma [J].
Jakiela, Bogdan ;
Bochenek, Grazyna ;
Sanak, Marek .
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2010, 120 (06) :214-221
[63]   Functional C3435T polymorphism of MDR1 gene:: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia [J].
Jamroziak, K ;
Mlynarski, W ;
Balcerczak, E ;
Mistygacz, M ;
Trelinska, J ;
Mirowski, M ;
Bodalski, J ;
Robak, T .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 72 (05) :314-321
[64]   CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia [J].
Jones, Terreia S. ;
Kaste, Sue C. ;
Liu, Wei ;
Cheng, Cheng ;
Yang, Wenjian ;
Tantisira, Kelan G. ;
Pui, Ching-Hon ;
Relling, Mary V. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (18) :3031-3037
[65]  
JONSSON G, 1995, DRUG METAB DISPOS, V23, P137
[66]   Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia [J].
Kamdem, Landry K. ;
Hamilton, Leo ;
Cheng, Cheng ;
Liu, Wei ;
Yang, Wenjiang ;
Johnson, Julie A. ;
Pui, Ching-Hon ;
Relling, Mary V. .
PHARMACOGENETICS AND GENOMICS, 2008, 18 (06) :507-514
[67]   Glucocorticoids impair bone formation of bone marrow stromal stem cells by reciprocally regulating microRNA-34a-5p [J].
Kang, H. ;
Chen, H. ;
Huang, P. ;
Qi, J. ;
Qian, N. ;
Deng, L. ;
Guo, L. .
OSTEOPOROSIS INTERNATIONAL, 2016, 27 (04) :1493-1505
[68]  
Kang Hee Gyung, 2011, Korean J Pediatr, V54, P317, DOI 10.3345/kjp.2011.54.8.317
[69]   The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter [J].
Kang, KI ;
Meng, X ;
Devin-Leclerc, J ;
Bouhouche, I ;
Chadli, A ;
Cadepond, F ;
Baulieu, EE ;
Catelli, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) :1439-1444
[70]   Persistent expression and function of P-glycoprotein on peripheral blood lymphocytes identifies corticosteroid resistance in patients with systemic lupus erythematosus [J].
Kansal, Amit ;
Tripathi, Deepak ;
Rai, Mohit K. ;
Agarwal, Vikas .
CLINICAL RHEUMATOLOGY, 2016, 35 (02) :341-349